Literature DB >> 16191414

Cytokines, STATs and liver disease.

Bin Gao1.   

Abstract

The Janus kinase-signal transducers and activators of transcription (JAK-STAT) signaling pathway, activated by more than 50 cytokines or growth factors, plays critical roles in a wide variety of cellular functions in the hematopoietic, immune, neuronal and hepatic systems. In the liver, this signaling pathway, activated by more than 20 cytokines, growth factors, hormones, and hepatitis viral proteins, plays critical roles in antiviral defense, acute phase response, hepatic injury, repair, inflammation, transformation, and hepatitis. This article reviews the biological significance of STAT1, 2, 3, 4, 5, 6 in hepatic functions and diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191414

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  103 in total

1.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

2.  Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice.

Authors:  A L Gavito; R Cabello; J Suarez; A Serrano; F J Pavón; M Vida; M Romero; V Pardo; D Bautista; S Arrabal; J Decara; A L Cuesta; A M Valverde; F Rodríguez de Fonseca; E Baixeras
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

3.  Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance.

Authors:  Sally Yu Shi; Rubén García Martin; Robin E Duncan; Diana Choi; Shun-Yan Lu; Stephanie A Schroer; Erica P Cai; Cynthia T Luk; Kathryn E Hopperton; Anthony F Domenichiello; Christine Tang; Mark Naples; Mark J Dekker; Adria Giacca; Khosrow Adeli; Kay-Uwe Wagner; Richard P Bazinet; Minna Woo
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

4.  Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases.

Authors:  Silvio Danese; Bin Gao
Journal:  Gut       Date:  2010-02       Impact factor: 23.059

5.  Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.

Authors:  Benting Ma; Junjie Zhu; Juan Tan; Yulei Mao; Lingyun Tang; Chunling Shen; Hongxing Zhang; Ying Kuang; Jian Fei; Xiao Yang; Zhugang Wang
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 6.  Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

Authors:  Andrew M Miller; Norio Horiguchi; Won-Il Jeong; Svetlana Radaeva; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

7.  Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers.

Authors:  Scott A Ochsner; Hélène Strick-Marchand; Qiong Qiu; Susan Venable; Adam Dean; Margaret Wilde; Mary C Weiss; Gretchen J Darlington
Journal:  Stem Cells       Date:  2007-07-19       Impact factor: 6.277

Review 8.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

9.  Profiling CCK-mediated pancreatic growth: the dynamic genetic program and the role of STATs as potential regulators.

Authors:  Grzegorz T Gurda; Jackie Y Wang; LiLi Guo; Stephen A Ernst; John A Williams
Journal:  Physiol Genomics       Date:  2011-10-18       Impact factor: 3.107

10.  Signaling pathways involved in liver injury and regeneration in rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure.

Authors:  Rodrigo García-Lastra; Beatriz San-Miguel; Irene Crespo; Francisco Jorquera; Marcelino Alvarez; Javier González-Gallego; María J Tuñón
Journal:  Vet Res       Date:  2009-09-03       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.